Status:

COMPLETED

Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment

Lead Sponsor:

University of Nebraska

Collaborating Sponsors:

Massachusetts Institute of Technology

San Mateo Medical Center

Conditions:

Cognitive Impairment

Eligibility:

All Genders

55-75 years

Brief Summary

A computer-based neuropsychological assessment tool is being developed to help primary care physicians detect neurological and psychiatric disorders. The first version will be tested against current t...

Detailed Description

The investigators are developing a computer-based neuropsychological assessment tool to help primary care physicians detect neurological and psychiatric disorders. To confirm the tool's efficacy, the ...

Eligibility Criteria

Inclusion

  • Any subject with mild impairment from who has already undergone or will soon undergo a full neuropsychological evaluation.
  • Subjects with Clinical Dementia Rating Scale CDR of 0.5-1.0 and Mini-Mental Score 20-26 (or MOCA equivalent, borderline/mild dementia) will be eligible for this group.
  • Normal controls without exclusion criteria.

Exclusion

  • Subjects whose impairment is severe enough to limit their ability to perform the computer-based tasks and/or to provide consent.
  • Subjects with history of learning disabilities or mental illness including major depression, bipolar disorder, anxiety disorders, and addiction are excluded because these problems can affect cognitive performance.

Key Trial Info

Start Date :

December 15 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 31 2012

Estimated Enrollment :

152 Patients enrolled

Trial Details

Trial ID

NCT01220674

Start Date

December 15 2010

End Date

October 31 2012

Last Update

September 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unversity of Nebraska Medical Center

Omaha, Nebraska, United States, 68198